InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by dEsparbes Eric, Chief Financial Officer. Officer active across 2 companies, notably PROGENITY, INC.. Aggregated, 6 filings have been published. The latest transaction was disclosed on 15 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€7,49010,387 shares@ €0.72110.0000% mcap100.0% of flow
Common Stock
SEC:0000899243-22-018428:0·
0231,693 shares0
Common Stock
SEC:0000899243-22-015063:0·
€8,2664,919 shares@ €1.680525.3% of flow
Common Stock
SEC:0000899243-22-006785:0·
€8,2664,919 shares@ €1.680550.7% of flow
Common Stock
SEC:0000899243-22-006785·
€8,0485,718 shares@ €1.407449.3% of flow
Common Stock
SEC:0000899243-21-033252·
€8,0485,718 shares@ €1.407424.7% of flow
Common Stock
SEC:0000899243-21-033252:0·
6 of 6 declarations
About dEsparbes Eric
Eric d'Esparbes is the Chief Financial Officer of Progenity, Inc. and Biora Therapeutics, Inc., companies specializing in health solutions. In this role, he oversees the financial management of both companies, including financial planning and analysis. With extensive experience in finance, he plays a key role in financial strategy and growth for the companies.
